Missing from the PBM hearings: value-based drug reimbursement - STAT

Missing from the PBM hearings: value-based drug reimbursement - STAT

Missing from the PBM hearings: value-based drug reimbursement

By ELIZABETH J. SEELEY AND SHAWN BISHOP

SUSAN WALSH/AP

In addition to oversight of pharmacy benefit manager rebates and payments, we need to improve the value of pharmaceutical spending in the U.S.

READ MORE